NOUR HEART

Nour Heart is a Connecticut-based biomedical company aimed at developing diagnostic and therapeutic products for the early detection, prevention, and treatment of myocardial ischemia in patients with ischemic heart disease... Nour Heart is currently developing and commercializing for human use its innovative and patented technologies related to Nourin molecular biomarkers for myocardial ischemia and the cardioprotective, Cyclocreatine Phosphate... Our team has extensive experience in drug development and commercialization according to USFDA regulations. Nour Heart's team includes cardiac pharmacologists, cardiac surgeon, transplant surgeon, intervention cardiologist, non-invasive cardiologist, experts in cardiac biomarkers (protein and molecular), drug process chemistry, formulation, and manufacturing according to FDA Good Laboratory Practice (GLP) and Good Manufacturing Practice (GMP), as well as extensive expertise in Active Pharmaceutical Ingredient (API) and finished product..

Also known as: Nour Heart, Inc.